A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found.
Men with prostate cancer that has spread to other parts of the body, known as metastatic cancer, and who have had their testosterone lowered with drug therapy are most likely to benefit. The study, recently published in Endocrine-Related Cancer, was conducted in prostate cancer cells and in mice.
Lowering of testosterone, also known as androgen-deprivation therapy, has long been the standard of care for patients with metastatic prostate cancer, but life expectancies vary widely for those who undergo this treatment. Testosterone is an androgen, the generic term for any compound that stimulates or controls development and maintenance of male characteristics by binding to androgen receptors.
The current findings hold promise for GCP therapy as a way to extend life expectancy of patients with low response to androgen-deprivation therapy.
Paramita Ghosh, an associate professor in the UC Davis School of Medicine, led the pre-clinical study with a team that included UC Davis Comprehensive Cancer Center Director Ralph de Vere White, a UC Davis distinguished professor of urology. Ruth Vinall in the UC Davis Department of Urology and Clifford Tepper in the UC Davis Department of Biochemistry and Molecular Medicine directed the studies in mice; Ghosh’s laboratory conducted the cell studies.
The research focused on GCP, a proprietary extract cultured from soybeans and shiitake mushrooms and marketed by Amino-Up of Sapporo, Japan. Researchers found that the combination of the compounds genistein and daidzein, both present in GCP, helps block a key mechanism used by prostate cancer cells to survive in the face of testosterone deprivation.
The research team had earlier shown that when a patient’s androgen level goes down, cancerous prostate cells kick out a protein known as filamin A, which is otherwise attached to the androgen receptor in the cell’s nucleus. The androgen receptor regulates growth of prostate cancer cells. Once filamin A leaves the cancerous cell’s nucleus, that cell no longer requires androgens to survive. Thus, loss of filamin A allows these cells to survive androgen deprivation, at and the cancer essentially becomes incurable.
The paper, titled “Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization,” shows for the first time that GCP keeps filamin A in the nucleus. As long as this protein remains attached to the androgen receptor, the cancerous cells need androgens to survive and grow. They die off when starved of androgens, thus prolonging the effects of androgen deprivation, which ultimately prolongs the patient’s life.
The team’s hypothesis is that metastatic prostate cancer patients with the weakest response to androgen-deprivation therapy could be given GCP concurrently with androgen deprivation therapy to retain Filamin A in the nucleus, thereby allowing cancer cells to die off.
The Latest Bing News on:
Prostate cancer
- This is how we do it: ‘Since having prostate cancer I can’t get an erection, but I still get just as much pleasure’on April 27, 2024 at 3:01 am
With penetrative sex no longer an option, Sebastian and Teresa have found different ways to satisfy one other ...
- WATCH: OJ Simpson died from metastatic prostate canceron April 27, 2024 at 12:30 am
In May 2023, Simpson announced that he'd been diagnosed with cancer, and LaVergne admits that he thought that the controversial star had beaten the disease at one point in time. He said: "I was pretty ...
- APCCC 2024: When to Do Tumor Genomic Profiling in Advanced Prostate Cancer and What?on April 26, 2024 at 3:55 pm
Advanced Prostate Cancer Consensus Conference (APCCC) meeting featured a session on the management of metastatic CRPC (mCRPC), and a presentation by Dr. Niven Mehra discussing when we should do tumor ...
- OJ Simpson’s Cause of Death Revealed as Prostate Canceron April 26, 2024 at 2:29 pm
The official cause of death of former football star and actor O.J. Simpson was announced Friday by his attorney and the executor of his estate. Malcolm Lavergne, who had been Simpson’s legal ...
- Prostate Cancer Summit: Unveiling the Latest Strategies to Beat Prostate Canceron April 26, 2024 at 8:53 am
When it comes to prostate cancer, sign up for free at the Prostate Cancer Sumit and gain clarity and confidence in your decision-making. It will be hosted by one of the leading authorities in men's ...
- Conference MDAngle: AUA 2024 Metastatic Prostate Canceron April 25, 2024 at 5:00 pm
These include updates on PSMA PET imaging, new data on PARP inhibitors, and updates from trials evaluating combination therapies. Coming soon: Dr Kelvin Moses will reflect on how new data from AUA ...
- Kurt Williams starts radiation treatment for prostate canceron April 25, 2024 at 11:06 am
Today is the day! Today is the first day of my radiation treatment at Sentara's Oncology and Radiation department.
- Masturbation can lower prostate cancer risk: doctoron April 24, 2024 at 12:26 pm
“Although the mechanisms are not completely understood, these studies fit with the idea that ejaculation can reduce prostate cancer by decreasing the concentration of toxins and crystal-like ...
- Does ejaculating often reduce your risk of prostate cancer?on April 24, 2024 at 10:30 am
In terms of men's health issues, prostate cancer features high on the agenda. It's the second most diagnosed cancer in men globally—closely followed by lung cancer. And it's the most common cancer in ...
- European Commission approves Astellas’ drug for expanded prostate cancer Treatmenton April 24, 2024 at 2:50 am
Astellas Pharma Inc. revealed that XTANDITM (enzalutamide) has received a label extension from the European Commission, marking it as the inaugural and only novel hormone therapy endorsed for ...
The Latest Google Headlines on:
Prostate cancer
[google_news title=”” keyword=”prostate cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
[/vc_column_text]
The Latest Bing News on:
Genistein-combined polysaccharide
- Feed has no items.
The Latest Google Headlines on:
Genistein-combined polysaccharide
[google_news title=”” keyword=”genistein-combined polysaccharide” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
1 Comments
rental trash dumpster
Hi! I’m at work browsing your blog from my new iphone! Just wanted to say I love reading your blog and look forward to all your posts! Carry on the great work!
My web-site; rental trash dumpster